Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279328 · ClinicalTrials.gov registry record · Phase 4
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
A Phase 4 study of Actinic Keratoses, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03279328 is a Phase 4 study of Actinic Keratoses that has completed, run by University of Arizona. The registered enrollment target is 30 participants, below the 96-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03279328, a Phase 4 study of Actinic Keratoses, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed project will be an open-label, split face, randomized controlled pilot study. Up to 60 patients with diffuse facial actinic keratosis will be enrolled in the study. The purpose of this study is to understand the change in skin appearance throughout 5-FU treatment course and to examine whether a topical corticosteroid and moisturizer can decrease severity and duration of skin inflammation after 5-FU treatment course.
Conditions Studied
Interventions
- DRUG Topical Steroid Ointment
- OTHER Vaseline
- DRUG Skin Barrier Moisturier
Study Locations (1)
Arizona
- University of Arizona - Banner University Medicine Dermatology - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2018-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03279328
The ClinicalTrials.gov registry entry for NCT03279328 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (69% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Actinic Keratoses appearing as the primary indexed condition, and to 3 interventions - of which Topical Steroid Ointment is the first listed.
NCT03279328 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT03279328 about?
NCT03279328 is a clinical study titled "Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents". This proposed project will be an open-label, split face, randomized controlled pilot study. Up to 60 patients with diffuse facial actinic keratosis will be enrolled in the study. The purpose of this study is to understand the change in skin appearance throughout 5-FU treatment course and to examine ...
What is the current status of trial NCT03279328?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2017-10-10. Estimated completion is 2018-07-31.
What conditions does trial NCT03279328 study?
This clinical trial studies the following conditions: Actinic Keratoses.
What interventions are being tested in trial NCT03279328?
The interventions under investigation include: Topical Steroid Ointment (DRUG), Vaseline (OTHER), Skin Barrier Moisturier (DRUG).
Who is sponsoring clinical trial NCT03279328?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03279328 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
RECRUITING · Phase 4
-
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
RECRUITING · NA
-
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
RECRUITING · NA
-
Photodynamic Therapy Incubation Times for Actinic Keratosis
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
ACTIVE NOT RECRUITING · Phase 3
-
Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.